| Product Code: ETC8833699 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the Philippines saw a steady increase in acitretin import shipments, with top exporting countries including India, Germany, USA, Metropolitan France, and Italy. The market showed low concentration levels in terms of the Herfindahl-Hirschman Index (HHI), which improved from very low in 2023 to low in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 6.92%, with a notable growth rate of 2.97% from 2023 to 2024. This indicates a positive trend in the acitretin market in the Philippines, driven by contributions from diverse exporting countries.

The acitretin market in the Philippines is primarily driven by its use in treating severe psoriasis and other dermatological conditions. As awareness of chronic skin disorders grows, so does the demand for retinoid-based treatments. However, strict guidelines around pregnancy risks and side effects limit widespread usage. Dermatological clinics and private hospitals remain the key distribution channels.
The acitretin market, primarily used for severe psoriasis and other skin disorders, is expanding steadily in the Philippines. Growing awareness of dermatological conditions and increased access to specialty dermatology clinics support this trend. However, the drugs teratogenic risks necessitate careful prescription and monitoring, which somewhat restricts its wider adoption. The rise of biologics and alternative therapies may influence future market dynamics.
The Acitretin market, primarily used for severe psoriasis and other dermatological conditions, faces challenges related to strict regulatory controls and high treatment costs. Patient adherence is often low due to side effects and the prolonged nature of therapy. In addition, awareness among both patients and healthcare providers about proper usage and monitoring requirements remains limited, impacting market growth. Accessibility in rural areas is also a concern, as specialty medications tend to be concentrated in urban healthcare facilities.
The market for acitretin, a drug used primarily for psoriasis and other skin conditions, shows promising growth in the Philippines due to increasing awareness of dermatological health. Rising incidences of chronic skin diseases and expanding dermatology services provide fertile ground for investment. Pharmaceutical companies can capitalize on opportunities by introducing advanced formulations and improving patient access through healthcare networks.
Acitretin, used primarily for severe psoriasis, is regulated by the Food and Drug Administration (FDA) to ensure drug safety and efficacy. The Philippine government requires pharmaceutical companies to secure registration and follow strict labeling and prescription guidelines due to the drugs teratogenic risks. Access to acitretin is controlled to minimize misuse, with patient education programs supported by the Department of Health to promote safe use.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Acitretin Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Acitretin Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Acitretin Market - Industry Life Cycle |
3.4 Philippines Acitretin Market - Porter's Five Forces |
3.5 Philippines Acitretin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Acitretin Market Revenues & Volume Share, By Dose strength, 2021 & 2031F |
3.7 Philippines Acitretin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Philippines Acitretin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Acitretin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing awareness about the effectiveness of acitretin in treating psoriasis in the Philippines |
4.2.2 Increase in disposable income leading to higher spending on healthcare and dermatological treatments |
4.2.3 Rise in prevalence of skin disorders and autoimmune diseases in the Philippines |
4.3 Market Restraints |
4.3.1 High cost of acitretin treatment compared to alternative therapies |
4.3.2 Potential side effects and safety concerns associated with acitretin use |
4.3.3 Limited availability of specialized healthcare professionals for prescribing and monitoring acitretin treatment |
5 Philippines Acitretin Market Trends |
6 Philippines Acitretin Market, By Types |
6.1 Philippines Acitretin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Acitretin Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Acitretin Market Revenues & Volume, By Branded, 2021- 2031F |
6.1.4 Philippines Acitretin Market Revenues & Volume, By Generics, 2021- 2031F |
6.1.5 Philippines Acitretin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Acitretin Market, By Dose strength |
6.2.1 Overview and Analysis |
6.2.2 Philippines Acitretin Market Revenues & Volume, By 10mg, 2021- 2031F |
6.2.3 Philippines Acitretin Market Revenues & Volume, By 25mg, 2021- 2031F |
6.2.4 Philippines Acitretin Market Revenues & Volume, By 50mg, 2021- 2031F |
6.3 Philippines Acitretin Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Philippines Acitretin Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.3.3 Philippines Acitretin Market Revenues & Volume, By Solid Organ Transplant, 2021- 2031F |
6.3.4 Philippines Acitretin Market Revenues & Volume, By Darier Disease, 2021- 2031F |
6.3.5 Philippines Acitretin Market Revenues & Volume, By Pityriasis Rubra Pilaris, 2021- 2031F |
6.4 Philippines Acitretin Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Philippines Acitretin Market Revenues & Volume, By Dermatology clinics, 2021- 2031F |
6.4.3 Philippines Acitretin Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.4.4 Philippines Acitretin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.5 Philippines Acitretin Market Revenues & Volume, By Ambulatory Surgical Centre, 2021- 2031F |
6.4.6 Philippines Acitretin Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Acitretin Market Import-Export Trade Statistics |
7.1 Philippines Acitretin Market Export to Major Countries |
7.2 Philippines Acitretin Market Imports from Major Countries |
8 Philippines Acitretin Market Key Performance Indicators |
8.1 Patient adherence rate to acitretin treatment regimen |
8.2 Number of dermatology clinics offering acitretin treatment in the Philippines |
8.3 Rate of successful outcomes and improvement in psoriasis symptoms with acitretin therapy |
9 Philippines Acitretin Market - Opportunity Assessment |
9.1 Philippines Acitretin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Acitretin Market Opportunity Assessment, By Dose strength, 2021 & 2031F |
9.3 Philippines Acitretin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Philippines Acitretin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Acitretin Market - Competitive Landscape |
10.1 Philippines Acitretin Market Revenue Share, By Companies, 2024 |
10.2 Philippines Acitretin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here